The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Neuropathy, a condition that affects individuals of all ages but is most common in older adults, often causes pain in the ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

Today we meet Craig. He suffered from neuropathy for 5-7 years. He feared the walker and wheelchair. His balance was very ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Our friends with Essential Neuropathy break down what Neuropathy actually is and how they can pinpoint the problem and find ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...